Editorial: Innovative strategies in overcoming glioblastoma: advancements in treatment and research - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Editorial: New Approaches to Combat Glioblastoma: Progress in Research and Treatment

  • By

  • Raphael Bertani

  • Fabio Torregrossa

  • Felipe Salvagni

  • June 17, 2026

Share

  • 1

    Glioblastoma (GBM) remains the most lethal primary brain tumor, with a median survival of approximately 15 months.

  • 2

    Tumor-treating fields are the only treatment addition showing survival benefits in GBM, while other candidates have largely failed.

  • 3

    GBM resistance arises from a network of pathways in an immunosuppressive microenvironment, necessitating combination therapies.

  • 4

    Non-invasive monitoring of GBM through plasma cfDNA is limited by low concentrations, while CSF detection shows higher accuracy.

  • 5

    The Research Topic includes diverse contributions aimed at identifying molecular targets and improving therapeutic strategies for GBM.

Original Source(s)

Editorial: Innovative strategies in overcoming glioblastoma: advancements in treatment and research

  • by Raphael Bertani, Fabio Torregrossa, Felipe Salvagni

  • June 17, 2026

Related Content

Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget’s disease with bone marrow involvement: a case report

Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms